United States · FDA National Drug Code directory
LISINOPRIL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68071-3064_1d8e4c5c-500f-be32-e063-6294a90a6f87
- Product NDC
- 68071-3064
- Form
- TABLET
- Composition / generic term
- Lisinopril
- Labeler
- NuCare Pharmaceuticals,Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20111101
- Source listing expiry
- 20261231
Source-listed ingredients
- LISINOPRIL — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET in 1 BOTTLE (68071-3064-2) · 68071-3064-2
- 30 TABLET in 1 BOTTLE (68071-3064-3) · 68071-3064-3
- 45 TABLET in 1 BOTTLE (68071-3064-5) · 68071-3064-5
- 60 TABLET in 1 BOTTLE (68071-3064-6) · 68071-3064-6
- 180 TABLET in 1 BOTTLE (68071-3064-8) · 68071-3064-8
- 90 TABLET in 1 BOTTLE (68071-3064-9) · 68071-3064-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →